Background: The suitability of the proximal landing zone remains one of the main limitations to thoracic endovascular aortic repair (TEVAR). The advent of custom-made scalloped stent grafts widens the endovascular options for patients with challenging anatomy. The objective of this study was to present our early and midterm results of custom-made scalloped thoracic stent grafts. Methods: Prospectively acquired data relating to patient demographics, procedure details, clinical outcome, and complications were analyzed. In addition, we analyzed preoperative and postoperative computed tomography scans to evaluate aneurysm morphology, graft placement, side-vessel patency, and endoleaks. Results: Twenty-one patients with a median age of 71 years (range, 35-81 years) underwent custom-made scalloped TEVAR, eight of whom had a concomitant hybrid repair. Procedural success was achieved in all cases. Proximal seal was achieved in all cases, with no type I endoleaks. There were no cases of retrograde dissection and no conversions to open repair. The median follow-up period was 36 weeks (range, 3-183 weeks). Two patients died in the hospital. Three patients suffered a stroke. Three patients had a type II endoleak, one of whom had significant sac enlargement requiring reintervention. One patient had a type III endoleak requiring reintervention. There were no cases of graft migration. Conclusions: Our midterm results show that custom-made scalloped TEVAR is an acceptable treatment of thoracic aortic aneurysms with a short proximal landing zone. Longer term outcome data are required to establish wider use of scalloped thoracic endografts. (J Vasc Surg 2014;60:1499-506.) 
Thoracic endovascular aortic aneurysm repair (TEVAR) is an established treatment of thoracic aortic disease in both the acute and elective setting. 1 TEVAR is associated with lower early mortality and morbidity compared with open surgical repair, making it an attractive therapeutic option. [2] [3] [4] The feasibility of TEVAR is determined by several anatomic factors, including landing zones. Adequate proximal and distal landing zones of healthy aorta are mandatory for endovascular treatment to prevent stent graft migration and to reduce the risk of endoleak.
Scalloped endografts are one strategy in overcoming the problem of a short proximal landing zone. These are custom-made covered stent grafts with a scallop designed to accommodate the origin of a supra-aortic vessel, which would otherwise be covered or require revascularization. Most often, the proximal scallop is to the left subclavian artery (LSCA), but it has also been successfully used to accommodate common carotid and innominate vessels either with extra-anatomic bypass for covered vessels or by use of fenestrated grafts as an alternative. [5] [6] [7] Distal celiac and superior mesenteric artery scallops have also been described. [8] [9] [10] In this paper, we discuss our early and midterm outcomes using TEVAR with a proximal scallop or fenestration in treating thoracic aortic disease with inadequate proximal landing zones.
METHODS
All cases were discussed at our specialist vascular multidisciplinary team meeting before their surgery. Our protocol was to select TEVAR with a custom-made scalloped stent graft in patients with a thoracic aortic aneurysm with a proximal landing zone of <20 mm (as measured From from the distal wall of the LSCA) and in cases in which there was significant angulation of the arch necessitating a longer length of landing zone for adequate graft apposition and seal.
Patients with more extensive aortic arch disease underwent scalloped TEVAR with arch vessel extra-anatomic revascularization or, more recently, endograft placement with a fenestration and a scallop.
All patients were entered into our postoperative surveillance program, undergoing follow-up computed tomography angiography at 3 months, 6 months, 1 year, and biannually thereafter in the absence of symptoms and complications. Prospectively acquired data relating to patient demographics, procedure details, clinical outcomes, and complications were analyzed. In addition, two vascular interventional radiologists (M.H. and A.A.) independently analyzed preoperative and postoperative scans to evaluate aneurysm morphology (aneurysm size, morphologic features, type and length of the proximal landing zones), graft placement, migration, supra-aortic vessel patency, and endoleaks.
Ethics approval was not required for this retrospective study.
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Stent grafts. We used the CE-marked custom-made Bolton Relay scalloped stent grafts (Relay NBS; Bolton Medical, Barcelona, Spain) (Fig 2) . These are self-expanding nitinol stents sutured onto polyester vascular graft fabric with a curved nitinol wire along the length of the graft to provide longitudinal support. In addition to the radiopaque end markers, there are four more markers delineating the position of the scallop. The delivery system consists of a series of coaxially arranged sheaths and catheters: a "stiff" hydrophilic introducer to deliver the device through the iliac arteries and a flexible sheath containing the stent graft that allows the device to track through the tortuous course of the thoracic aorta. In cases in which proximal readjustment is required, the delivery system allows distal tip recapture. 12 Stent grafts were manufactured according to preoperative computed tomography angiography measurements, with a custom-made scallop created in situ. Turnaround time from order to delivery was 4 to 6 weeks.
Graft sizing. Stent grafts were sized using the Philips Extended Brilliance Workspace (Philips Medical Systems, Best, The Netherlands). The true landing zone as well as the working landing zone was assessed. The working landing zone incorporated the vessel around which the scallop fits. A minimum of 20-mm working landing zone was required to obtain an adequate proximal seal with scalloped stent grafts. The diameter of the aorta at the native landing zone was assessed with images corrected to the centerline followed by 10% to 20% stent oversizing. All stent measurements and intraoperative C-arm positioning were determined preoperatively by one operator (M.H.) and agreed to by a second operator as well as the manufacturer.
Technique. Informed written consent was obtained from all patients. Except for patient 8, who underwent TEVAR under sedation and regional anesthesia, all other patients had surgery under general anesthesia. In cases of hybrid repair, revascularization procedures preceded endovascular repair. Patients were nursed in a dedicated vascular high-dependency unit; those undergoing stand-alone TEVAR were discharged the following day in the absence of postoperative complications.
The procedure steps have been previously described by Kashef et al. 7 All patients had a femoral cutdown as means of access for thoracic stent insertion. A pigtail catheter was introduced into the aortic arch for intraprocedural angiography through a left brachial artery puncture.
The stent grafts were introduced through a 60-cm sheath in the common femoral artery; 5000 IU of unfractionated heparin was administered at this stage. The delivery system was introduced into the mid-descending aorta, followed by further advancement of the secondary sheath into the aortic arch. The LSCA was identified by means of arch angiography through the pigtail catheter. Two angiograms at perpendicular angles were obtained to aid positioning of the scallop. An angiogram "opening" the aortic arch was used to align the distal marker of the scallop just distal to the LSCA. A perpendicular angiogram was also obtained to aid clock face alignment. The stent graft was adjusted to ensure that the scallop's side markers were positioned on either side of the LSCA.
In cases of misalignment, the graft was pulled back to the descending aorta, reoriented, and then readvanced. Systolic blood pressure was lowered gradually to 70 mm Hg just before stent graft deployment to avoid the "windsock" effect. The grafts were deployed in accordance with the manufacturer's instructions.
A completion angiogram was obtained in all cases.
RESULTS
Twenty-one patients with a median age of 71 years (range, 35-81 years) underwent scalloped TEVAR. Thirteen of these had a stand-alone scalloped TEVAR and eight had scalloped TEVAR with extra-anatomic revascularization. Of those who underwent extra-anatomic bypass, five underwent an arch hybrid repair and three had visceral revascularization.
Patient demographics are described in Table I . Procedure details are listed in Table II .
The median hospital stay was 8 days (2-157 days). Patients 2, 3, and 4 were admitted to the intensive care unit for 7, 21, and 79 days, respectively. The median follow-up period was 36 (3-183) weeks. Endoleaks and complications are shown in Table III .
Seal and endoleaks. Proximal seal was achieved in all cases with no type I endoleaks to date.
A type II endoleak was demonstrated at 52 weeks in patient 4, which persisted at 128 weeks and resulted in asymptomatic enlargement of the aneurysm sac (from 45 mm to 73 mm). This patient had an arch hybrid repair with innominate reimplantation, carotid-carotid bypass, and left common carotid artery (LCCA)eLSCA bypass. The scallop was to the neoinnominate artery with resultant type II endoleak from the covered LSCA. This was successfully treated by endovascular embolization of the LSCA with a combination of an Amplatzer vascular plug and coils.
Patient 7 had a type II endoleak from multiple intercostal arteries detected on completion computed tomography angiography, with no significant sac enlargement during the follow-up period of 16 weeks and no reintervention.
Patient 18 developed a type II endoleak 1 year after TEVAR with no significant sac enlargement.
Patient 10 had a type III endoleak from LSCA fenestration around his covered branch stent, which persisted after balloon molding. There was no significant sac enlargement recorded at 23-week follow-up. The fenestration diameter in this patient was particularly wide (16 mm), making a bridging stent seal difficult. This was avoided with patient 18, in whom a 10-mm fenestration was used with no endoleak.
Stroke. Patients 3, 4, and 5 suffered a stroke. They had an arch hybrid, a visceral hybrid, and a stand-alone scalloped TEVAR, respectively. Patient 3 suffered postoperative right-sided weakness secondary to multiple left middle cerebral artery territory embolic infarcts. Patient 4 had multiple bilateral embolic infarcts resulting in bilateral leg weakness. Patient 5 suffered acute blindness secondary to a right posterior cerebral artery territory infarct on a background of a previous contralateral posterior cerebral artery stroke.
Mortality. The 30-day mortality was 5%. Patients 3 and 7 died in the hospital after 3 and 22 weeks, respectively, both from multiorgan failure and hospital-acquired pneumonia in the intensive care unit. Both had undergone TEVAR with a concomitant visceral hybrid repair for extent II thoracoabdominal aortic aneurysm. Three other patients died during the follow-up period: patient 5 in the community from unknown causes at 22 weeks; patient 10 from a pontine hemorrhage at 31 weeks; and patient 1, who died in the hospital after open surgical repair of an abdominal aortic aneurysm 120 weeks after his uncomplicated TEVAR.
Other complications. Patient 7 suffered paraplegia after visceral hybrid repair. This was likely due to extensive coverage of the aorta and occurred despite insertion of a spinal drain. The median hospital stay for the first 10 patients was 14 days compared with 3.5 days for the latter 11 patients. All in-hospital deaths, strokes, paraplegia, cardiovascular complications, and endoleaks occurred in the first half of the study.
Results in patients undergoing TEVAR without extra-anatomic bypass. Thirteen patients with a median age of 71 years (35-80 years) had a stand-alone scalloped TEVAR. The median follow-up period was 53 weeks (6-120 weeks). The median hospital stay was 4 days (2-14 days). There were no in-hospital deaths, no conversions to open surgical repair, no early or late supra-aortic vessel occlusions, and no retrograde dissections. One patient (patient 5) suffered a stroke, as described before. She died 6 months later at home. There were no cases of postoperative paraplegia, and no patient had documented cardiac complications or aortic rupture during the followup period. There were no cases of type I endoleak or significant sac enlargement on follow-up imaging. None of the patients in this cohort required reintervention to date.
DISCUSSION
Since Kruger et al first described the use of custommade scalloped endografts in cases of inadequate proximal landing zone, 13 the technique has become increasingly used in both the thoracic and abdominal aorta to preserve flow into branch vessels. The published literature on the use of proximal scallops remains sparse, however.
Our group has previously published the first case series of four patients describing early outcomes after proximal scalloped TEVAR, demonstrating the feasibility and safety of this technique. 7 Proximal seal was achieved in all cases in our series with no type I endoleaks. These results suggest that scalloped TEVAR is a viable therapeutic option for thoracic aortic aneurysms with a short proximal landing zone. Scalloped TEVAR allows the distal aortic arch to be considered a robust landing zone when the scallop is for the LSCA. More data are required, however, to establish whether this applies to more proximal aortic arch.
The custom-made scallop may complement modular branch stent grafts, providing an entirely endovascular solution for aortic arch disease.
14 Scalloped endografts may be used when the aortic pathology involves the origin of the LSCA, LCCA, or innominate artery. They are less invasive and less technically challenging compared with modular stent grafts, resulting in shorter procedure times and potentially fewer complications. Scalloped endografts provide an alternative therapeutic option when modular stent grafts are not suitable, for instance, when there is a short proximal landing zone (<2 cm) or in cases of a tortuous aneurysm neck.
The scallop is a continuation of the stent without the polyester vascular graft. This therefore exposes a small part of the aortic arch to what is essentially a bare-metal stent. To date, we have not encountered any cases of retrograde aortic dissection or aortic wall perforation. Longterm follow-up is needed, however, to assess durability of this design.
Similar to the Relay thoracic stent grafts, scalloped endografts have a curved nitinol wire along their length providing longitudinal support, flexibility, and torque response. This design has proved durable during shortterm and midterm follow-up. 4, [15] [16] [17] To date, we have had no cases of support wire failure with the scalloped endografts.
Lu et al published a study of 22 patients with type B aortic dissection, two of whom had TEVAR with LSCA scallops and two with LSCA fenestrations; the remainder had a hybrid repair with conventional stent grafts and arch revascularization. The study's small numbers and the younger population with a lower burden of comorbidities as well as the different aortic diseases make a direct comparison with our data difficult. 18 We used scalloped endografts not only in patients with distal aortic arch disease but also in patients with more proximal disease after revascularization procedures with scallops to the LSCA, LCCA, and innominate arteries. The alternative for these patients would have been aortic arch replacement surgery on cardiopulmonary bypass, with significant associated mortality and morbidity, particularly in a population of elderly patients. [19] [20] [21] [22] Recently, our unit and others have demonstrated outcomes from hybrid thoracic aortic aneurysm repair comparable to those of conventional open techniques. 23 One of the main advantages of scalloped TEVAR is preservation of LSCA flow without the need for extraanatomic bypass. Routine LSCA coverage during TEVAR remains the subject of much debate. Although outcomes after routine LSCA coverage in the absence of a dominant left vertebral artery are deemed acceptable, there are reports of arm claudication, ischemia, and stroke. Therefore, many authors advocate preservation of LSCA flow whenever possible. 24 The 30-day mortality after TEVAR with LSCA coverage is 7% to 11%, with a 30-day stroke rate of 2% to 6%. 25, 26 Reports on disability and quality of life vary from no disability to development of severe arm claudication in a third of patients. Patients with a left vertebral artery diameter of <3 mm are more likely to develop symptoms. [27] [28] [29] Scalloped TEVAR provides an alternative to LSCA coverage, with lower complication rates obviating the need for open revascularization in some cases. Larger studies are needed, however, to confirm these findings as well as to establish long-term outcomes and durability of scalloped stent grafts.
Our series describes outcomes with use of scalloped stent grafts in a heterogeneous group of patients with different aortic aneurysm morphologies and etiologies to illustrate the different potential uses of the device. The complication rates, however, reflect the different groups' surgical risks. Patients undergoing TEVAR for a thoracic aortic aneurysm have a very different risk profile from that of elderly patients with extensive thoracoabdominal aortic disease with multiple comorbidities requiring TEVAR and hybrid repair. Unsurprisingly, the former group has excellent outcomes after scalloped TEVAR alone.
Patients in the second half of our series had fewer complications and shorter hospital stay compared with patients in the first half, regardless of the type of surgery they underwent. Although some of the differences may be due to the shorter follow-up period for the patients in the second half, they are also likely to reflect an initial learning curve. Furthermore, as our center's experience with endovascular techniques improves, our selection of patients is consonantly being refined. Patients with atheromatous aortic arch have a high risk of embolic infarcts, 9 making this a relative contraindication to TEVAR, perhaps even more so with scalloped grafts as more manipulation is needed for accurate deployment. For some of our patients, this was the only therapeutic option, with the risk of aortic rupture thought to outweigh that of potential complications.
We are in the process of assessing whether the use of robotic guidewire and catheter placement and manipulation will reduce the incidence of embolic phenomena in high-risk patients as this may result in more accurate, less traumatic wire and catheter positioning.
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CONCLUSIONS
Our early and midterm outcomes suggest that scalloped TEVAR may provide an acceptable alternative treatment option for thoracic aortic aneurysms involving the great vessels, particularly when it is used without extraanatomic bypass. Further studies, in particular long-term outcome data, are needed to establish the advantages and durability of custom-made scalloped thoracic endografts.
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